Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1

• मुख्य लेखकों: Jiong Li (लेखक), Xiangjun Ma (लेखक), Faying Xu (लेखक), Yuanliang Yan (लेखक), Weiqing Chen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

AbstractContext Cholangiocarcinoma with highly heterogeneous, aggressive, and multidrug resistance has a poor prognosis. Although babaodan (BBD) combined with cisplatin improved non-small cell lung cancer efficacy, its impact on overcoming resistance in cholangiocarcinoma remains unexplored.Objectiv...